Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB26FX4EP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,610
Award facts
- Contract value 100% obligated
- $10,610.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,610.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg/10 mL vials of Imfinzi, an oncology pharmaceutical product. The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $1 billion IDC (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. The IDC vehicle serves multiple government customers, including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical supplier within the federal medical supply chain. As a child contract under this larger vehicle, the Imfinzi delivery order represents routine pharmaceutical procurement supporting military medical operations and demonstrates the vendor's ongoing capability to meet specialized oncology medication requirements across the defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FX4EP?
SPE2DB26FX4EP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FX4EP worth?
The government has obligated $10,610 on SPE2DB26FX4EP.
Is contract SPE2DB26FX4EP an order under another contract?
Yes. SPE2DB26FX4EP is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4EP competed?
The extent of competition for SPE2DB26FX4EP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award